drugset / Trial / NCT02487238

Pediatric FEcal Microbiota Transplant for Ulcerative Colitis

NCT02487238 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The PediFETCh study is a pilot trial designed to assess the feasibility of fecal microbiota transplants for the therapy of pediatric ulcerative colitis (UC) and pediatric inflammatory bowel disease-unclassified (IBD-U). Investigators will test the hypothesis that a protocol of twice-weekly retention enemas delivered over six weeks, using fecal transplant material from a healthy donor, will improve clinical and biological disease markers in patients with pediatric UC or IBD-U.

Timeline

Start
2015-11
Primary completion
2018-12
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Enema Unknown — Rectal

Indications